Christopher Lai

Christopher Lai is a highly accomplished business professional with a diverse educational background.

He studied BA in Neuroscience, Economics, and Genetics at Columbia University in the City of New York, showcasing his strong academic foundation.

Additionally, he obtained his High School Diploma from Harrow School, reflecting his early commitment to education and learning.

Throughout his career, Christopher has held pivotal roles in various organizations, demonstrating his strong leadership skills and strategic vision.

Currently, he serves as a Partner at The March Fund, where he contributes his expertise in finance and business development.

Previously, Christopher was the Co-Chairman at Celsius Holdings, Inc., highlighting his experience in executive management and corporate governance.

His notable past positions include being an Investor at Horizons Ventures and specializing in Investment Banking - Mergers and Acquisitions at Mooreland Partners, where he honed his financial acumen.

Moreover, he has hands-on experience in Finance & Business Development at IRX Therapeutics, Inc. (now Brooklyn ImmunoTherapeutics), showcasing his versatile skill set.

Christopher's entrepreneurial spirit is evident through his role as the Co-Founder & President at DormAid LLC, where he played a key role in building a successful business from the ground up.